About DRS Alexia Pharma Private Limited
Data last updated:
DRS Alexia Pharma Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 May 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U52310KL2014PTC036657. Its GSTIN is 32AAFCD1198N1ZF (Kerala).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Chandran Parlikkatt Narayanan (Managing Director) and Velappan Nadar Thanuvan Nadar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thrissur, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.96 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹10.9 Lakh (net margin 1.4%) and EBITDA of ₹15.61 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Drs Alexia. As per MCA filings, the company has open charges of ₹25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alexiapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressBuilding No 50/946 – 2 Laloor Road, Elthuruth, Thrissur, Kerala, India – 680611
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of DRS Alexia Pharma Private Limited
The main business activity of DRS Alexia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of DRS Alexia Pharma Private Limited FY 2025 filings available
DRS Alexia Pharma Private Limited reported revenue of ₹7.96 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of DRS Alexia Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 3% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DRS Alexia Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.9 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of DRS Alexia Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DRS Alexia Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of DRS Alexia Pharma Private Limited
DRS Alexia Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mission Research Laboratories (India) Private Limited | ₹8.01 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Chandigarh, India |
| Orange Biotech Private Limited | ₹8.01 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Shahabad Markanda, Haryana, India |
| Aagam Life Sciences Private Limited | ₹7.99 Cr (FY 2024) | •••• | •••• | 64.0% | •••• | Ahmedabad, Gujarat, India |
| Valugen Pharma Private Limited | ₹7.97 Cr (FY 2025) | •••• | •••• | -71.0% | •••• | Bangalore, Karnataka, India |
| Bracing Lifesciences Private Limited | ₹7.97 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| DRS Alexia Pharma Private Limited this company | ₹7.96 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Thrissur, Kerala, India |
| American Vitamins India Private Limited | ₹7.96 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | New Delhi, Delhi, India |
| Orient Drugs Private Limited | ₹7.95 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Malappuram, Kerala, India |
| Ndcare Nirogam Private Limited | ₹7.95 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Amritsar, Punjab, India |
| Pine Pharma Private Limited | ₹7.92 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Glocal Vision Private Limited | ₹7.9 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below DRS Alexia Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of DRS Alexia Pharma Private Limited
DRS Alexia Pharma Private Limited is audited by R RAJAN ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R RAJAN ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of DRS Alexia Pharma Private Limited
DRS Alexia Pharma has 10 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandran Parlikkatt Narayanan | Managing Director | 28 May 2014 | 12 Years 4 Months | Current |
| Velappan Nadar Thanuvan Nadar | Director | 23 Jan 2017 | 9 Years 8 Months | Current |
| Thamarassery Megha Mohanan | Director | 23 Jan 2017 | 9 Years 8 Months | Current |
| Suja | Director | 23 Jan 2017 | 9 Years 8 Months | Current |
| Shiji Sudarsanan Krishnaveni | Director | 28 May 2014 | 12 Years 4 Months | Current |
| Karipparambil Athira Ramakrishnan | Director | 23 Jan 2017 | 9 Years 8 Months | Current |
Ownership and Shareholding of DRS Alexia Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of DRS Alexia Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2017 | The South Indian Bank Limited | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Associated Brands with DRS Alexia Pharma Private Limited
DRS Alexia Pharma operates one associated brand: Drs Alexia. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical marketing and provision of quality medicines in India. | alexiapharma.com |
Employees and EPFO Compliance at DRS Alexia Pharma Private Limited
DRS Alexia Pharma Private Limited has a workforce of 8 employees as of Mar 31, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on DRS Alexia Pharma Private Limited
DRS Alexia Pharma Private Limited has 10 board changes on record since 2014: 10 appointments. The latest: Karipparambil Athira Ramakrishnan was appointed as Director on 23 Jan 2017.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for DRS Alexia Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DRS Alexia Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DRS Alexia Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DRS Alexia Pharma Private Limited
DRS Alexia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCD1198N1ZF | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DRS Alexia Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DRS Alexia Pharma Private Limited
DRS Alexia Pharma is an active private limited company based in Thrissur, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 May 2014 (12+ years old) and is registered under CIN U52310KL2014PTC036657.
DRS Alexia Pharma reported revenue of ₹7.96 Cr for FY 2025 (up 3% YoY).
DRS Alexia Pharma has 10 current directors:
- Chandran Parlikkatt Narayanan - Managing Director
- Velappan Nadar Thanuvan Nadar - Director
- Thamarassery Megha Mohanan - Director
- Suja - Director
- Shiji Sudarsanan Krishnaveni - Director
- Karipparambil Athira Ramakrishnan - Director
- Chandrika Mullakkal Velayudhan - Director
- Sabitha Balan Mathramkott - Director
- Umesh - Director
- Manoj Vijayan - Director
DRS Alexia Pharma reported a net profit of ₹10.9 Lakh (net margin 1.4%) and EBITDA of ₹15.61 Lakh (EBITDA margin 2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of DRS Alexia Pharma is 3% over three years and 5% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of DRS Alexia Pharma is 32AAFCD1198N1ZF, registered in Kerala.
The CIN (Corporate Identification Number) of DRS Alexia Pharma is U52310KL2014PTC036657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DRS Alexia Pharma was incorporated on 28 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of DRS Alexia Pharma by revenue are Mission Research Laboratories (India) Private Limited, Orange Biotech Private Limited, Aagam Life Sciences Private Limited, Valugen Pharma Private Limited, Bracing Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Karipparambil Athira Ramakrishnan was appointed as Director on 23 Jan 2017. Sabitha Balan Mathramkott was appointed as Director on 23 Jan 2017. Suja was appointed as Director on 23 Jan 2017. DRS Alexia Pharma has 10 board changes on record in total.
DRS Alexia Pharma can be reached through the website alexiapharma.com. Its registered office is in Thrissur, Kerala, India.